![](images/sepfull.gif) |
Hot Pursuit
15-Jun-24
|
![](images/sepfull.gif) |
|
|
|
|
|
Biocon’s Andhra Pradesh facility gets 3 USFDA observations
|
Biocon said that US Food and Drug Administration (USFDA) issued three observations after the good manufacturing practices (GMP) inspection conducted at its API manufacturing facility situated at Visakhapatnam, Andhra Pradesh.
|
|
|
The good manufacturing practices was conducted on 14 June 2024 and closed the inspection with three observations. The company said that it will respond to the USFDA within the stipulated timeframe.
Biocon is an innovation led global biopharmaceuticals company, engaged in the production of therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as Generic Formulations in the US, Europe & key emerging markets. It also has a pipeline of promising novel assets in immunotherapy under development.
The company had reported 56.74% decline in consolidated net profit to Rs 135.5 crore despite of 3.79% rise in revenue from operations to Rs 3,917.1 crore in Q4 FY24 over Q4 FY23.
The scrip fell 1.06% to end at Rs 334.65 on Friday, 15 June 2024.
|
|
Previous News |
Biocon’s Andhra Pradesh facility gets 3 USFDA observations
(
Hot Pursuit
-
15-Jun-24
16:32
)
|
|
Biocon consolidated net profit rises 167.80% in the September 2023 quarter
(
Results
-
Announcements
10-Nov-23
17:28
)
|
|
Barometers pares all gains ; realty shares decline
(
Market Commentary
-
Mid-Session
24-May-24
10:36
)
|
|
Biocon Biologics signs distribution agreement with Sandoz
(
Corporate News
-
22-Dec-23
19:57
)
|
|
Biocon Ltd up for fifth session
(
Hot Pursuit
-
06-Feb-24
13:00
)
|
|
Biocon Ltd spurts 1.83%, gains for third straight session
(
Hot Pursuit
-
22-Mar-24
13:05
)
|
|
Biocon Ltd spurts 0.71%, rises for fifth straight session
(
Hot Pursuit
-
19-Jun-23
13:00
)
|
|
Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
(
Corporate News
-
09-Nov-23
09:15
)
|
|
Biocon consolidated net profit declines 29.78% in the June 2023 quarter
(
Results
-
Announcements
11-Aug-23
07:47
)
|
|
Biocon to hold board meeting
(
Corporate News
-
02-Jul-22
09:59
)
|
|
Biocon gains after arm inks distribution agreement with Sandoz
(
Hot Pursuit
-
26-Dec-23
10:40
)
|
|
|
![](images/sepfull.gif) |
Other Stories |
![](images/sepfull.gif) |
|
|
|
|
|
|
|